Rnc Capital Management LLC Trimmed Stake in Pfizer INC (PFE) as Market Value Rose

September 16, 2018 - By Mark Mitchell

Pfizer Inc. (NYSE:PFE) LogoInvestors sentiment decreased to 0.78 in 2018 Q2. Its down 0.11, from 0.89 in 2018Q1. It dropped, as 52 investors sold PFE shares while 754 reduced holdings. 112 funds opened positions while 518 raised stakes. 3.98 billion shares or 0.73% less from 4.01 billion shares in 2018Q1 were reported. Huntington Natl Bank reported 1.55 million shares. Bruce & Communication holds 4.01% or 555,332 shares in its portfolio. Comml Bank Hapoalim Bm stated it has 0.72% in Pfizer Inc. (NYSE:PFE). Pictet North America Advsrs Sa has invested 0.06% in Pfizer Inc. (NYSE:PFE). 1.06M were accumulated by Bnp Paribas Asset Holdg. Stonebridge Capital Advisors Ltd Liability Corporation owns 0.18% invested in Pfizer Inc. (NYSE:PFE) for 23,335 shares. Twin Cap Management accumulated 580,450 shares. Karpas Strategies Llc holds 105,741 shares or 1.66% of its portfolio. Moreover, Deutsche Savings Bank Ag has 1.11% invested in Pfizer Inc. (NYSE:PFE). First City Mngmt Inc has 88,522 shares for 2.3% of their portfolio. Evergreen Management has 0.25% invested in Pfizer Inc. (NYSE:PFE) for 74,493 shares. Mogy Joel R Investment Counsel Inc stated it has 0.76% of its portfolio in Pfizer Inc. (NYSE:PFE). Estabrook Mngmt holds 386,161 shares or 0% of its portfolio. First Heartland Consultants holds 0.18% of its portfolio in Pfizer Inc. (NYSE:PFE) for 14,324 shares. Confluence Wealth Mngmt Lc, a Oregon-based fund reported 16,824 shares.

Since May 1, 2018, it had 0 insider buys, and 5 selling transactions for $7.57 million activity. $418,774 worth of Pfizer Inc. (NYSE:PFE) was sold by OLSON LAURIE J on Monday, August 13. $190,117 worth of stock was sold by CORNWELL W DON on Monday, June 4. The insider READ IAN C sold $4.76 million.

Rnc Capital Management Llc decreased its stake in Pfizer Inc (PFE) by 92.75% based on its latest 2018Q2 regulatory filing with the SEC. Rnc Capital Management Llc sold 969,395 shares as the company’s stock rose 17.09% with the market. The institutional investor held 75,792 shares of the health care company at the end of 2018Q2, valued at $2.75 million, down from 1.05M at the end of the previous reported quarter. Rnc Capital Management Llc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $251.84B market cap company. The stock increased 0.26% or $0.11 during the last trading session, reaching $42.96. About 15.94 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 19.90% since September 16, 2017 and is uptrending. It has outperformed by 4.28% the S&P500.

Rnc Capital Management Llc, which manages about $4.08 billion and $1.42 billion US Long portfolio, upped its stake in Carnival Corporation (NYSE:CCL) by 339,538 shares to 345,698 shares, valued at $19.81 million in 2018Q2, according to the filing. It also increased its holding in Walgreen Boots Alliance Inc by 334,810 shares in the quarter, for a total of 408,584 shares, and has risen its stake in Cisco Systems Inc (NASDAQ:CSCO).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on October, 30. They expect $0.75 earnings per share, up 11.94 % or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.40B for 14.32 P/E if the $0.75 EPS becomes a reality. After $0.81 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -7.41 % negative EPS growth.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: 247Wallst.com which released: “Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018” on August 22, 2018, also Seekingalpha.com with their article: “Pfizer receives Breakthrough Therapy designation for PF-06651600 for the treatment of patients with alopecia areata” published on September 05, 2018, Seekingalpha.com published: “Pfizer Achieves Success In Rare Heart Disease Study” on August 28, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer prices $5B debt offering” published on September 05, 2018 as well as Seekingalpha.com‘s news article titled: “Your Cancer Highlight: A Pfizer-Merck KGaA Collab Bears Fruit In The Competitive Kidney Cancer Market” with publication date: September 13, 2018.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

Among 8 analysts covering Pfizer (NYSE:PFE), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. Pfizer had 10 analyst reports since April 5, 2018 according to SRatingsIntel. On Wednesday, August 1 the stock rating was maintained by Credit Suisse with “Neutral”. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, August 1. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Cantor Fitzgerald on Thursday, June 7. Barclays Capital downgraded the shares of PFE in report on Thursday, April 5 to “Equal-Weight” rating. Bank of America maintained Pfizer Inc. (NYSE:PFE) on Wednesday, August 1 with “Buy” rating. The company was maintained on Friday, April 13 by Jefferies. The firm earned “Outperform” rating on Wednesday, May 2 by BMO Capital Markets. Barclays Capital maintained the shares of PFE in report on Thursday, August 23 with “Equal-Weight” rating. The firm has “Overweight” rating by Morgan Stanley given on Thursday, August 23.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.